Publications by authors named "G De Pouvourville"
Purpose: This study aimed to document utility values and the Visual Analog Scale (VAS) with the 5-level version of the EQ-5D questionnaire in a large sample of patients with inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC).
Methods: QALY-MICI was a cross-sectional survey across three sources in France. Data were collected between 2019 and 2022 for patients 18 and over.
Background: This study aimed to describe treatment patterns in patients with myasthenia gravis (MG) in France.
Methods: A retrospective cohort analysis was performed using the French National Health Data System (SNDS) database between 2008 and 2019. MG patients were identified using ICD-10 codes during hospitalization and/or long-term disease.
Article Synopsis
- The study aims to create standardized methodologies and processes for vaccine appraisal in the EU to improve decision-making in health technology assessment (HTA).
- Researchers identified significant differences in vaccine evaluation practices across EU member states through literature reviews and expert consultations, leading to the development of three guiding principles.
- The principles emphasize the need for better terminology, inclusive appraisal processes, and improved real-world data collection to support consistent and timely access to vaccines in the EU.
Background: Ibrutinib is a Bruton's tyrosine kinase inhibitor indicated for the first-line treatment and relapse of chronic lymphocytic leukaemia (CLL), Waldenström's macroglobulinemia (WM) and mantle cell lymphoma (MCL). This study aimed to describe the characteristics of CLL patients treated with ibrutinib and its effectiveness, safety, and treatment pattern in real life.
Methods: All patients covered by the general health scheme (approximately 80% of the French population) with a first ibrutinib dispensation from August 1, 2017 (date of reimbursement in France) to December 31, 2020, were identified in the French National Health Insurance database (SNDS).
Article Synopsis
- Remote patient monitoring (RPM) in cancer care improves quality of life, survival rates, and reduces medical resource use, prompting a budget impact analysis of a nurse navigator-led RPM program based on the CAPRI trial in France.
- Data from 559 cancer patients indicated that the RPM program saved €377 per patient from the French national health insurance perspective and €504 from an all-payers perspective over an average follow-up of 4.58 months, primarily due to fewer hospitalizations.
- The findings suggest significant cost savings associated with the CAPRI RPM program, underlining the economic benefits of RPM in cancer care, while further research is needed to evaluate long-term cost-effectiveness and real-world scalability.